AN overweight in pharmaceuticals led to the Barings UK Growth fund lagging the performance of the UK Equity Income portfolio, according to manager Charles Deptford.
The £37.95m Baring Equity Income trust is first quartile over three years, and second quartile over one year in the IMA Equity Income sector, according to Lipper figures up until November 8, 2006 (bid-to-bid)...
‘Important to have an anchor’
Lack of innovation for solutions
Some 2,000 consumers affected
Achievements, charity work and other happy snippets